Kolexia
Artignan Xavier Oncologie radiothérapie
Artignan Xavier
Oncologie radiothérapie
Clinique De La Cote D'emeraude
Saint-Malo, France
104 Activités
576 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Tumeurs du rectum Carcinomes Carcinome épidermoïde Néphrocarcinome Tumeurs colorectales Métastase tumorale Tumeurs du foie Carcinome pulmonaire à petites cellules

Collaborateurs

Voir plus
Chamois Jerome
Chamois Jerome
Clinique De La Cote D'emeraude, Saint-Malo, France
Tariel Edouard
Tariel Edouard
Urologie Rennes Nord, Redon, France
Bonniol Romain
Bonniol Romain
Urologie Rennes Nord, Redon, France
Delreux Arnaud
Delreux Arnaud
Urologie Rennes Nord, Redon, France

Industries

Voir plus
Astellas
6 collaboration(s)
Dernière en 2022
Janssen
5 collaboration(s)
Dernière en 2023
Ipsen
4 collaboration(s)
Dernière en 2023
Bayer
4 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer: A Phase 2, Randomized, Open-Label, Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer
Essai Clinique (MacroGenics)   18 mars 2024
Bladder-ART: Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer: A Randomized Multicentre Phase II Study
Essai Clinique (Unicancer)   09 novembre 2023
Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancer.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   10 octobre 2023
Néofirinox: Randomized Phase III Study Comparing Preoperative Chemoradiotherapy Alone Versus Neoadjuvant Chemotherapy With Folfirinox Regimen Followed by Preoperative Chemoradiotherapy for Patients With Resectable Locally Advanced Rectal Cancer
Essai Clinique (Unicancer)   30 août 2023
OSCAR: Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable): A Double-blind Randomised Phase III Trial Evaluating the Efficacy of ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability and Not Elected for Docetaxel or Androgen Receptor Targeted Agents
Essai Clinique (Bayer)   10 mai 2023
DARIUS: A Randomized Non-comparative Phase II Multicentric Trial on Short Term Darolutamide (ODM-201) Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer
Essai Clinique (Bayer)   01 mars 2023
PEACE2: A Randomized Phase III, Factorial Design, of Cabazitaxel and Pelvic Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse
Essai Clinique (Sanofi)   28 octobre 2022
HypProMet: Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy Monocentric, Comparative, Randomized, Open Study
Essai Clinique (Saint-Gregoire Private Hospital Center)   09 mai 2022
AxiPRO: A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First Line
Essai Clinique (Weprom)   02 mai 2022